Sanofi has returned to T-cell engager (TCE) territory via an agreement to pay $180 million in the near term for a phase ...

UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for ...

Orphan designation reflects unmet need in RP rather than evidence of efficacy, while offering development incentives and ...

A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to ...